The Influence of Risk Factors on the Choice of Therapeutic Method in Peripheral Arterial Disease

1. Fowker FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2010 and 2010: a systemic review and analysis. Lancet. 2013;382:1329-1340.10.1016/S0140-6736(13)61249-0Search in Google Scholar

2. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116:1509-1526.10.1161/CIRCRESAHA.116.30384925908725Search in Google Scholar

3. Jacoby DS, Mohler ER. Peripheral arterial disease. Risk factor identification and modification. In: Abela GS, editor. Peripheral Vascular Disease. Basic Diagnostic and Therapeutic Approaches. Lippincott Williams and Wilkins; 2004. p. 190-9.Search in Google Scholar

4. Zipes D, Libby P. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 11th Edition; 2018.Search in Google Scholar

5. Herman G, Gornik HL, Barrett C, et al.2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e726-e779.10.1161/CIR.000000000000050228320816Search in Google Scholar

6. Tseng A, Louka B, Shamoun F, Esser H, Morcos R, McBane, Misra RS. The Evolving Treatment of Peripheral Arterial Disease through Guideline - Directed Recommandations, J Clin Med. 2018 Jan; 2018;7(1):9.Search in Google Scholar

7. Costel M. Bolile arterelor periferice. In Ginghină C et al. Mic tratat de cardiologie. București. Editura Academiei Române; 2017; p. 967-77.Search in Google Scholar

8. Aboyans V, Ricco JB, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. European Heart Journal. 2018;39(9):763-816.10.1093/eurheartj/ehx09528886620Search in Google Scholar

9. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Lie- benthal C, Niebauer J, Hooper J, Volk HD, Coats AJ, Anker SD. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 2000;102:3060-3067.10.1161/01.CIR.102.25.3060Search in Google Scholar

10. Ostergren J, Sleight P, Dagenais G, Danisa K, Bosch J, Qilong Y, Yusuf S. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J. 2004;25:17-24.10.1016/j.ehj.2003.10.03314683738Search in Google Scholar

11. Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, Mukamal KJ. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA.2012;308:1660-1667. doi:10.1001/jama.2012.13415.10.1001/jama.2012.13415373310623093164Search in Google Scholar